# Nicotine Patch - Bioequivalence Study

> **NCT02089308** · PHASE1 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 74 (actual)

## Conditions studied

- Healthy Smokers

## Interventions

- **DRUG:** Test treatment : V0116 transdermal patch
- **DRUG:** Reference treatment : Nicotine transdermal patch

## Key facts

- **NCT ID:** NCT02089308
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2014-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02089308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02089308, "Nicotine Patch - Bioequivalence Study". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT02089308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*